Forcura And Medalogix Unveil Integrated Technology To Elevate Home Health Agency Performance

Newly Merged Company Launches First Joint Product to Improve Patient Outcomes and Streamline Clinical and Operational Workflows

Jacksonville, FL and Nashville, TN /PRNewswire/ - Forcura and Medalogix, which merged in March 2025, today announced the launch of its first integrated product offering—designed to help home health agencies optimize patient referral management, intake and start-of-care while delivering smarter, faster, and more confident clinical care.

By uniting the Forcura Workflow for Referrals platform and Medalogix Pulse Referrals & Admissions product, home health teams can streamline referral and intake documentation, improve care coordination, and enhance OASIS accuracy—all without increasing headcount.

"Our goal is to offer technology that strengthens patient outcomes and the clinical team experience," said Elliott Wood, CEO of Forcura and Medalogix. "This integrated solution is purpose-built to remove complexity, reduce cognitive burden, and accelerate the delivery of informed, compassionate care. It helps clinicians and administrative staff do more with the staff they already have."

With the CMS mandate requiring OASIS documentation for all payers beginning July 1, many agencies face the daunting reality of a 30–40% increase in documentation workload. The integrated solution allows organizations to absorb this burden by automating manual tasks and offering AI-powered insights instantaneously drawn from referral packets, clinical notes, and OASIS assessments—freeing staff to focus on patient care.

Pulse Referrals & Admissions surfaces key clinical and operational insights to support accurate and compliant documentation, faster intake, and better care planning. "We designed this product not to replace clinicians, but to be their companion," said Laura Brinkoetter, Chief Product Officer at Forcura and Medalogix. "It gives them quick access to the most relevant information from the referral and admission documentation, helping them plan care more effectively and spend more time with their patients."

Unlike other tools that rely solely on rules-based reconciliation, Pulse Referrals and Admissions leverages large language models to synthesize and reconcile documentation from the referral, the comprehensive assessment, the OASIS, add-on evaluations, and clinical narratives to recommend HIPPS codes, diagnoses, and potential OASIS corrections. It streamlines the work of field clinicians, quality managers, and coders alike—reducing redundancy, improving accuracy, outcomes, and care plans, protecting home health value-based care reimbursement, and increasing confidence across teams.

Home health providers interested in learning more about the new integrated platform can register to attend an educational webinar airing July 1 and July 9, 2025. Visit here to register.

About Forcura
Forcura, a healthcare SaaS technology company, facilitates continuity of care and improves business performance for providers via its intelligent workflow, collaboration and connectivity solutions. The company is deeply committed to empowering better patient care and enabling a holistic view of the patient anywhere in the continuum. The company is a 2024 - 2025 Best in KLAS® Winner, is a certified Great Place to Work™ employer, and has ranked for the eighth consecutive year on the Inc. 5000. For more information visit forcura.com.

About Medalogix
Founded in 2012, Medalogix is a pioneer in the post-acute care space, offering unique data analytics solutions to transform home health and hospice agencies. Leveraging cutting-edge data science, machine learning, and innovative cloud technology, Medalogix equips clinicians and agencies to provide the right care at the right time, resulting in improved patient outcomes and reduced costs to the healthcare system. The company's machine learning solutions have demonstrated their effectiveness in reducing hospitalizations, facilitating appropriate transitions to end-of-life care, and optimizing visit utilization for patients.